Company intelligence / Profile preview

Poppins

Paris, Île-de-France, Francepoppins.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Poppins has developed a CE-marked digital medical device delivering cognitive-musical therapy via a mobile app for children with dyslexia. Clinical studies—including a double-blind randomized controlled trial—demonstrate significant improvements in reading accuracy and speed. The solution is reimbursed by French insurers, used both B2B and B2C, with strong clinical validation and exclusive partnerships with major music labels to enhance engagement

Therapeutic areas: Neurology
Modalities: Digital therapeuticMobile applicationCognitive-musical training program
Industry: Digital Health Medical Devices

Partnerships

Disney Music GroupWarner Music GroupMultiple French health insurance companies

Beyond the preview

Go deeper on Poppins.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poppins.

Explore the full profile